{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "1520068", "DateCompleted": {"Year": "1992", "Month": "10", "Day": "07"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["jpn"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0021-4884", "JournalIssue": {"Volume": "41", "Issue": "5", "PubDate": {"Year": "1992", "Month": "May"}}, "Title": "Arerugi = [Allergy]", "ISOAbbreviation": "Arerugi"}, "ArticleTitle": "[Role of thromboxane A2 and prostaglandin I2 in the increase of airway responsiveness in dogs after ozone exposure].", "Pagination": {"StartPage": "595", "EndPage": "600", "MedlinePgn": "595-600"}, "Abstract": {"AbstractText": ["To investigate the role of thromboxane (Tx) A2 and prostaglandin (PG) I2 in the development of airway responsiveness after ozone exposure, we measured the airway responsiveness to inhaled methacholine (Mch), TxB2 and 6-keto-PGF1 alpha levels in bronchoalveolar lavage fluid (BALF) in 18 dogs after ozone exposure. Airway responsiveness to Mch was determined by Astograph (7 Hz oscillation method), and ozone exposure was carried out for 2 hr at an ozone level of 3.01 +/- 0.05 ppm (mean +/- SEM). Airway responsiveness to Mch increased significantly after ozone exposure (p less than 0.001). TxB2 levels in BALF were not affected by ozone exposure, but the levels of 6-keto-PGF1 alpha decreased significantly after ozone exposure (p less than 0.001). The ratio of TxB2/6-keto-PGF1 alpha increased significantly after ozone exposure, and the change in this ratio correlated significantly with the change of airway responsiveness to Mch (p less than 0.01, r = 0.654). These results suggest that airway hyperresponsiveness after ozone exposure is induced by the relative increase of TxA2 due to the decrease of PGI2."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "First Department of Internal Medicine, School of Medicine, Showa University."}], "Identifier": [], "LastName": "Imai", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adachi", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Idaira", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sugeta", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hiyama", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Takahashi", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tanaka", "ForeName": "Y", "Initials": "Y"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Arerugi", "NlmUniqueID": "0241212", "ISSNLinking": "0021-4884"}, "ChemicalList": [{"RegistryNumber": "54397-85-2", "NameOfSubstance": "Thromboxane B2"}, {"RegistryNumber": "57576-52-0", "NameOfSubstance": "Thromboxane A2"}, {"RegistryNumber": "58962-34-8", "NameOfSubstance": "6-Ketoprostaglandin F1 alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "DCR9Z582X0", "NameOfSubstance": "Epoprostenol"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "6-Ketoprostaglandin F1 alpha"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Atmosphere Exposure Chambers"}, {"QualifierName": ["etiology", "metabolism"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": ["physiology"], "DescriptorName": "Epoprostenol"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": ["physiology"], "DescriptorName": "Thromboxane A2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Thromboxane B2"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "5", "Day": "1"}, {"Year": "1992", "Month": "5", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "5", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1520068"]}}], "PubmedBookArticle": []}